[{"id":"06fab5d5-c5d5-4468-a08d-023b001b63e4","acronym":"","url":"https://clinicaltrials.gov/study/NCT05995028","created_at":"2023-08-16T16:08:27.573Z","updated_at":"2024-07-02T16:35:33.722Z","phase":"Phase 1","brief_title":"Universal 4SCAR7U Targeting CD7-positive Malignancies","source_id_and_acronym":"NCT05995028","lead_sponsor":"Shenzhen Geno-Immune Medical Institute","biomarkers":" CD7","pipe":"","alterations":" ","tags":["CD7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 4SCAR7U"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 10/31/2023","start_date":" 10/31/2023","primary_txt":" Primary completion: 09/30/2026","primary_completion_date":" 09/30/2026","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2023-10-12"}]